Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Derma Sciences Inc (NASDAQ:DSCI)

3.99
Delayed Data
As of May 27
 +0.095 / +2.44%
Today’s Change
2.85
Today|||52-Week Range
8.10
-12.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$103.3M

Company Description

Derma Sciences, Inc. is a medical technology company, focused on wound care. The company operates its business through three segments: Advanced Wound Care and Traditional Wound Care. The Advanced Wound Care segment includes MEDIHONEY, BIOGUARD, AMNIOEXCEL, AMNIOMATRIX, DERMAGRAN, ALGICELL AG, XTRASORB and TCC-EZ. The Traditional Wound Care segment consists of gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices. It manufactures and markets adhesive bandages and related first aid products for the medical, industrial, private label and retail markets. The company also offers skin care products, which includes barrier creams and ointments, antibacterial cleansing foams and sprays, shampoos and body washes, hand sanitizers, bath additives, body oils and moisturizers to nursing homes, hospitals, home healthcare agencies and other institutions. Derma Sciences was founded on September 10, 1984 and is headquartered in Princeton.

Contact Information

Derma Sciences, Inc.
214 Carnegie Center
Princeton New Jersey 08540
P:(609) 514-4744
Investor Relations:

Employees

Shareholders

Other institutional53.42%
Mutual fund holders21.76%
Individual stakeholders19.00%

Top Executives

Stephen T. WillsExecutive Chairman & Chief Executive Officer
Frederic EignerExecutive Vice President-Operations
John E. YetterChief Financial Officer & Executive Vice President
Alan W. DuntonChief Medical Officer
Barry J. WolfensonGroup President-Advanced Wound Care